Interstitial lung disease in a female patient with rheumatoid arthritis
https://doi.org/10.14412/1996-7012-2014-1-27-30
Abstract
Rheumatoid arthritis (RA) is a progressive disease, resulting in joint deformation and development of severe functional disorders. Meanwhile, RA patients frequently have systemic inflammatory disorders of internal organs, which may significantly worsen quality of life, labor capacity, and be a factor determining the prognosis. Idiopathic interstitial pneumonia is of particular interest. This disease is characterized by unfavorable prognosis due to progressive fibrous rearrangement of the lung. We report a clinical case of RA with signs of interstitial lung disease.
About the Authors
Yuliya Valeryavna Averkieva
Kemerovo State Medical Academy, Ministry of Healthcare of the Russian Federation, Kemerovo, Russia; Voroshilova ul.. 22A, Kemerovo, 650029 Russia
Russian Federation
Russian Federation
T A Raskina
Kemerovo State Medical Academy, Ministry of Healthcare of the Russian Federation, Kemerovo, Russia; Voroshilova ul.. 22A, Kemerovo, 650029 Russia
Russian Federation
Russian Federation
O S Malyshenko
Kemerovo State Medical Academy, Ministry of Healthcare of the Russian Federation, Kemerovo, Russia; Voroshilova ul.. 22A, Kemerovo, 650029 Russia
Russian Federation
Russian Federation
M A Volykova
Regional Clinical Hospital for War Veterans, Kemerovo, Russia; 50 let Oktyabrya ul., Kemerovo, 650000 Russia
Russian Federation
Russian Federation
O M Maslova
Regional Clinical Hospital, Kemerovo, Russia; pr. Oktyabr’skiy, 22, Kemerovo, 650000 Russia
Russian Federation
Russian Federation
References
1. <div><p>Бестаев ДВ, Каратеев ДЕ, Насонов ЕЛ. Интерстициальное поражение легких при ревматоидном артрите. Научно-практическая ревматология. 2012;50(6):63–9. [Bestaev DV, Karateyev DE, Nasonov EL. Intersitial lung involvement in rheumatoid arthritis. Rheumatology Science and Practice. 2012;50(6):63–9.]. DOI: http://dx.doi.org/10.14412/1995-4484-2012-1296.</p><p>Сулимов ВА, Маколкин ВИ, Фоминых ЕВ и др. Бронхолегочные поражения при ревматоидном артрите. Лечащий врач. 2010;11:57–61. [Sulimov VA, Makolkin VI, Fominykh EV i dr. Bronkholegochnye porazheniya pri revmatoidnom artrite. Lechashchii vrach. 2010;11:57–61.]</p><p>Fathi M, Vikgren J, Boijsen M, et al. Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum. 2008;59(5):677–85. DOI: 10.1002/art.23571.</p><p>Насонов ЕЛ, редактор. Ревматология. Национальное руководство. Москва: ГЭОТАР-Медиа; 2008. [Nasonov EL, redaktor. Revmatologiya. Natsional'noe rukovodstvo. Moskva: GEOTAR-Media; 2008.]</p><p>Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008;63 Suppl 5:v1–v58. DOI: 10.1136/thx.2008.101691.</p><p>Richeldi L, Davies HR, Ferrara G, Franco F. Corticosteroids for idiopathic pulmonary fibrosis. Cohrane Database Syst Rev. 2003;(3):CD002880.</p><p>Hagiwara K, Sato T, Takagi-Kobayashi S, et al. Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis. J Rheumatol. 2007;34(5):1151–4. Epub 2007 Apr 15.</p><p>Demedts M, Behr J, Buhl R, et al. Highdose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. 2005;353(21):2229–42. DOI: http://dx.doi.org/10.1056/NEJMoa042976.</p><p>Gehr J, Maier K, Degenkolb B, et al. Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Am J Respir Crit Care Med. 1997;156(6):1897–901. DOI: http://dx.doi.org/10.1164/ajrc-cm.156.6.9706065.</p><p>Насонов ЕЛ. Ревматоидный артрит как общемедицинская проблема. Терапевтический архив. 2004;76(5):5–7. [Nasonov EL. Rheumatoid arthritis as a general medical problem. Terapevticheskii arkhiv. 2004;76(5):5–7.]</p><p>Насонов ЕЛ, Насонова ВА. Ревматология: Национальное руководство. Москва: ГЭОТАР-Медиа, 2008. [Nasonov EL, Nasonova VA. Revmatologiya: Natsional'noe rukovodstvo. Moskva: GEOTAR-Media, 2008.]</p><p>Park JH, Kim DS, Park IN, et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular diseaserelated subtypes. Am J Respir Crit Care Med. 2007;175(7):705–11. DOI: http://dx.doi.org/10.1164/rccm.200607-912OC.</p><p>Dawson JK, Fewins HE, Desmond J, et al. Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis. Ann Rheum Dis. 2002;61(6):517–21. DOI: http://dx.doi.org/10.1136/ard.61.6.517.</p><p>Kinder BW, Collard HR, Koth L, et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med. 2007;176(7):691–7. DOI: http://dx.doi.org/10.1164/rccm.200702-220OC. Epub 2007 Jun 7.</p><p>Steen VD, Conte C, Owens GR, Medsger TA Jr. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum. 1994;37(9):1283–9. DOI: http://dx.doi.org/10.1002/art.1780370903.</p></div><br />
Review
For citations:
Averkieva YV, Raskina TA, Malyshenko OS, Volykova MA, Maslova OM. Interstitial lung disease in a female patient with rheumatoid arthritis. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2014;8(1):27-30. (In Russ.) https://doi.org/10.14412/1996-7012-2014-1-27-30
Views:
2069
Email this article 